Open Access
Subscription Access
Myeloperoxidase-463G/A Polymorphism in Patients with Diabetic Nephropathy in Sikkim, India
Diabetic nephropathy (DN) is one of the most common causes of end-stage renal disease (ESRD). Despite major advances made in the area of diagnosis and treatment of DN, death cases related to this ailment are not significantly reduced. Thus it is important to identify the risk factors for this condition.
User
Font Size
Information
- Singh, D. K., Winocour, P. and Farrington, K., Nature Rev. Endocrinol., 2011, 7, 176– 184.
- Piedrafita, F. J., Molander, R. B., Vansant G, Orlova, E. A., Pfahl, M. and Reynolds, W. F., J. Biol. Chem., 1996, 271, 14412– 14420.
- The Diabetes Control and Complications (DCCT) Research Group. Kidney Int., 1995, 47, 1703–1720.
- Rovira-Llopis, S., Rocha, M., Falcon, R., de Pablo, C., Alvarez, A., Jover, A. and Hernandez-Milares, A., Antioxid. Redox Signal., 2013, 19, 1452–1458.
- Ministry of Health and Family Welfare, Government of India, National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke 2013. Available from: pib.nic.in/newsite/PrintRelease.
Abstract Views: 501
PDF Views: 153